Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calavo Growers (CVGW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Calavo Growers (CVGW) over the last 17 years, with Q4 2025 value amounting to $61.2 million.

  • Calavo Growers' Cash & Equivalents rose 723.12% to $61.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $61.2 million, marking a year-over-year increase of 723.12%. This contributed to the annual value of $61.2 million for FY2025, which is 723.12% up from last year.
  • According to the latest figures from Q4 2025, Calavo Growers' Cash & Equivalents is $61.2 million, which was up 723.12% from $63.8 million recorded in Q3 2025.
  • Over the past 5 years, Calavo Growers' Cash & Equivalents peaked at $63.8 million during Q3 2025, and registered a low of $368000.0 during Q3 2021.
  • Its 5-year average for Cash & Equivalents is $17.1 million, with a median of $4.2 million in 2023.
  • In the last 5 years, Calavo Growers' Cash & Equivalents crashed by 8970.05% in 2021 and then skyrocketed by 556198.93% in 2025.
  • Quarter analysis of 5 years shows Calavo Growers' Cash & Equivalents stood at $1.9 million in 2021, then increased by 9.28% to $2.1 million in 2022, then grew by 1.5% to $2.1 million in 2023, then surged by 2627.45% to $57.0 million in 2024, then increased by 7.23% to $61.2 million in 2025.
  • Its Cash & Equivalents was $61.2 million in Q4 2025, compared to $63.8 million in Q3 2025 and $60.4 million in Q2 2025.